Communiqué from the Annual General Meeting of Ortivus AB (publ) on 27 May 2026

Communiqué from the Annual General Meeting of Ortivus AB (publ) on 27 May 2026

Annual ReportThe Annual Report and Auditor's Report as well as the Consolidated Financial Statements and Consolidated Auditor's Report for the financial year were presented, and the income statements and balance sheets for the parent company and the group were adopted. Discharge from LiabilityThe meeting granted discharge from liability to the members of the Board of Directors and the Chief Executive Officer. FeesThe meeting resolved that a total fee of SEK 450,000 (prev. year SEK 875,000) shall be paid to the Board of Directors, distributed as SEK 300,000 to the Chairman (prev. year SEK 350,000) and SEK 150,000 (prev. year SEK 175,000) to board members who are not major shareholders in the company. The fee to the audit firm was resolved to be paid in accordance with reasonable invoicing. Board of Directors and Chairman of the BoardThe meeting resolved to re-elect Peter Edwall, Anna Klevby Dalgaard, and Anna-Carin Strandberg. Anna-Carin Strandberg was re-elected as Chairman of the Board. AuditorThe meeting resolved to re-elect the audit firm BDO in Stockholm as auditor of the company. It is noted that the authorized public accountant Beata Lihammar will continue to serve as the auditor in charge. Address by the Chief Executive OfficerIn his address, Ortivus AB's CEO Gustaf Nordenhök commented on the financial year 2025 and the developments during the first quarter of 2026.

Ortivus AB (publ)The Board of Directors

Contacts

For further information, please contact

Gustaf Nordenhök, CEO

Phone +46 8 446 45 00

About Ortivus

Ortivus has extensive experience in mobile communication solutions and a unique understanding of clinical healthcare. We develop interactive and user-friendly solutions that support diagnostics, increase efficiency, and deliver long-term cost savings for healthcare providers. By integrating our solutions with electronic health records, dispatch systems, and national registries, we ensure fast and secure information management, a crucial factor in creating a more integrated care process. Our solutions save valuable time for healthcare professionals, optimise resource use, and reduce the need for avoidable patient transports, resulting in more cost-effective and patient-centred care. With our combination of advanced technology and deep clinical expertise, we support our customers in meeting the healthcare challenges of today and tomorrow.

Ortivus Class A and Class B shares are listed on the NASDAQ First North Growth Market and the company’s Certified Adviser is FNCA Sweden AB. Read more about our solutions at www.ortivus.com

Attachments

PRESS RELEASE